Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,300 papers from all fields of science
Search
Sign In
Create Free Account
enkephalin degrading enzyme
Known as:
enkephalin exoaminopeptidase
, aminoenkephalinase
, enkephalin aminopeptidase
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Aminopeptidase
Narrower (1)
puromycin-sensitive aminopeptidase
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
An Endogenous Aminoenkephalinase Inhibitor: Purification and Characterization of Arg0‐Met5‐Enkephalin from Bovine Striatum
K. Hui
,
Ee‐Sing Lo
,
M. Hui
Journal of Neurochemistry
1994
Corpus ID: 1024191
Abstract: Arg0‐Met5‐enkephalin (Arg0‐MEK) was isolated from bovine striatum and purified to homogeneity. The peptide was…
Expand
1987
1987
Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
M. Hachisu
,
T. Hiranuma
,
+4 authors
H. Umezawa
European Journal of Pharmacology
1987
Corpus ID: 43803818
1985
1985
Proctolin: a potent inhibitor of aminoenkephalinase.
K. Hui
,
M. Hui
,
N. Ling
,
A. Lajtha
Life Science
1985
Corpus ID: 5764350
1982
1982
Inhibitors of a Rat Brain Enkephalin Aminopeptidase
G. Wagner
,
J. Dixon
Journal of Neurochemistry
1982
Corpus ID: 20414334
Abstract: Eight protease inhibitors of microbiological origin were examined as potential inhibitors of a homogeneous rat brain…
Expand
Highly Cited
1981
Highly Cited
1981
Purification and characterization of an enkephalin aminopeptidase from rat brain.
G. Wagner
,
M. Tavianini
,
K. Herrmann
,
J. Dixon
Biochemistry
1981
Corpus ID: 11270693
Rat brain enkephalin aminopeptidase was purified to apparent electrophoretic homogeneity. Enzyme activity was monitored during…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE